Emtricitabine / tenofovir Alternatives Compared
Emtricitabine / tenofovir | Emtricitabine / tenofovir alafenamide | Truvada |
|
---|
Emtricitabine / tenofovir | Emtricitabine / tenofovir alafenamide | Truvada (emtricitabine / tenofovir) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection, Occupational Exposure, Nonoccupational Exposure. emtricitabine / tenofovir may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection. emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, HIV Infection, Occupational Exposure, Nonoccupational Exposure. Truvada may also be used for purposes not listed in this medication guide. |
Related suggestions Pre-Exposure Prophylaxis
|
|||||||||||||||
More about Emtricitabine / tenofovir | More about Emtricitabine / tenofovir alafenamide | More about Truvada (emtricitabine / tenofovir) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Emtricitabine / tenofovir has an average rating of 5.9 out of 10 from a total of 40 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 37% reported a negative effect. |
Emtricitabine / tenofovir alafenamide has an average rating of 6.9 out of 10 from a total of 16 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 27% reported a negative effect. |
Truvada has an average rating of 6.3 out of 10 from a total of 37 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: emtricitabine / tenofovir side effects in more detail. |
See also: emtricitabine / tenofovir alafenamide side effects in more detail. |
See also: Truvada side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
View all Truvada prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
AccessPak for HIV PEP Basic, Truvada | Descovy | Other emtricitabine / tenofovir brands include: AccessPak for HIV PEP Basic | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
25.7 hours |
25.7 hours |
25.7 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 238 drugs are known to interact with emtricitabine / tenofovir:
|
A total of 238 drugs are known to interact with emtricitabine / tenofovir alafenamide:
|
A total of 238 drugs are known to interact with Truvada:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
August 02, 2004 |
April 04, 2016 |
August 02, 2004 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.